443 related articles for article (PubMed ID: 6174631)
41. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
42. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.
Juretić A; Malenica B; Juretić E; Klein J; Nagy ZA
J Immunol; 1985 Mar; 134(3):1408-14. PubMed ID: 2578505
[TBL] [Abstract][Full Text] [Related]
43. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts.
Orosz CG; Zinn NE; Sirinek L; Ferguson RM
Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878
[TBL] [Abstract][Full Text] [Related]
44. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
[TBL] [Abstract][Full Text] [Related]
45. MIs locus recognition by a cloned line of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.
Braciale VL; Braciale TJ
J Immunol; 1981 Sep; 127(3):859-62. PubMed ID: 6455473
[TBL] [Abstract][Full Text] [Related]
46. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
Nakamura I; Nakano K; Cudkowicz G
J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
[TBL] [Abstract][Full Text] [Related]
47. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
Dennert G; De Rose M
J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
[TBL] [Abstract][Full Text] [Related]
48. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
[TBL] [Abstract][Full Text] [Related]
49. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
Fujiwara H; Levy RB; Shearer GM
J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
[TBL] [Abstract][Full Text] [Related]
50. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
51. Fine specificity of a continuously growing killer cell clone specific for H-Y antigen.
von Boehmer H; Hengartner H; Nabholz M; Lernhardt W; Schreier MH; Haas W
Eur J Immunol; 1979 Aug; 9(8):592-7. PubMed ID: 91527
[TBL] [Abstract][Full Text] [Related]
52. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
Sihvola M; Hurme M
J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
[TBL] [Abstract][Full Text] [Related]
53. Frequency of responsiveness to the H-Y antigen among the B10.W lines.
Vucak I; Raska K; Nagy ZA; Klein J
J Immunol; 1983 Jul; 131(1):325-8. PubMed ID: 6863919
[TBL] [Abstract][Full Text] [Related]
54. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
55. Naturally occurring cytotoxic T lymphocyte precursors with specificity for an Ig idiotype.
Dohi Y; Yamada K; Ohno N; Aoki M; Takagaki Y; Nisonoff A; Shinka S
J Immunol; 1988 Dec; 141(11):3804-9. PubMed ID: 2460550
[TBL] [Abstract][Full Text] [Related]
56. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
Moser G; Burakoff SJ; Abbas AK
J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
Lucas CJ; Levy RB; Shearer GM
J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
[TBL] [Abstract][Full Text] [Related]
58. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
Levy RB; Shearer GM
J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
[TBL] [Abstract][Full Text] [Related]
59. Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect.
Bevan MJ
J Immunol; 1977 Apr; 118(4):1370-4. PubMed ID: 66290
[TBL] [Abstract][Full Text] [Related]
60. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen.
Rammensee HG; Fink PJ; Bevan MJ
J Immunol; 1984 Nov; 133(5):2390-6. PubMed ID: 6207228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
